UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 SCHEDULE 13G/A
                    Under the Securities Exchange Act of 1934
                                Amendment No. 3

                           Immtech Pharmaceuticals, Inc.
                                (Name of Issuer)

                               Common Stock Shares
                         (Title of Class of Securities)

                                   452519101
                                 (CUSIP Number)

                                May 12, 2008

             (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

[x] Rule 13d-1(b)

[ ] Rule 13d-1(c)

[ ] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).




                               CUSIP No. 452519101


       1.    Names of Reporting Persons.
             I.R.S. Identification Nos. of above persons (entities only).

             Ferris, Baker Watts, Incorporated

       2.    Check the Appropriate Box if a Member Of a Group (See Instructions)

             [ ] (a)
             [X] (b)

       3.    SEC Use Only

       4.    Citizenship or Place of Organization

             Delaware

       5.    Sole Voting Power: 0
Number of
Shares           6.  Shared Voting Power: 0
Beneficially
Owned by         7.  Sole Dispositive Power:  0
Each Reporting
Person With      8.  Shared Dispositive Power: 515,676

       9.    Aggregate Amount Beneficially Owned by Each Reporting Person
             515,676

       10.   Check if the Aggregate Amount in Row (9) Excludes Certain Shares
             (See Instructions)

       11.   Percent of Class Represented by Amount in Row (9) 3.31%

       12.   Type of Reporting Person (See Instructions) IA




Item 1. (a)  Issuer: Immtech Pharmaceuticals, Inc.

             1.      Address:
                     One North End Avenue
		     New York, NY 10282



Item 2. (a)  Name of Person Filing:
             Ferris, Baker Watts, Inc.

        (b)  Address of Principal Business Offices:

             100 Light Street
	     Baltimore, MD 21202

        (c)  Citizenship:
             Delaware Corporation

        (d)  Title of Class of Securities
             Common stock

        (e)  CUSIP Number: 452519101

Item 3. Ferris, Baker Watts, Inc. is a broker or dealer in
accordance with ss.240.13d-1(b)(1)(ii)(A).

Item 4.  Ownership

         Please see Items 5 - 9 and 11 for each cover sheet for each filing
separately

Item 5.  Ownership of Five Percent or Less of a Class [X]

	 As of the date of this filing, Ferris, Baker Watts, Inc. is the
	 beneficial owner of less than five percent of the
	 outstanding common shares of Immtech Pharmaceuticals, Inc.

Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

         If any other person is known to have the right to receive or the
	 power to direct the receipt of dividends from, or the proceeds from
	 the sale of, such securities, a statement to that effect should be
	 included in response to this item and, if such interest relates to
	 more than 5 percent of the class, such person should be identified.
	 A listing of the shareholders of an investment company registered
	 under the Investment Company Act of 1940 or the beneficiaries of
	 employee benefit plan, pension fund or endowment fund is not
	 required.






Item 7.  Identification and Classification of the Subsidiary Which Acquired the
Security  Being Reported on By the Parent Holding Company

         Not Applicable

Item 8.  Identification and Classification of Members of the Group

         Not Applicable


Item 9.  Notice of Dissolution of Group

         Not Applicable

Item 10. Certification

         By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and held in the ordinary
course of business and were not acquired and are not held for the purpose of or
with the effect of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.





                                    SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

Date:  May 20, 2008
                                       Ferris, Baker Watts, Inc.

                                       By: /s/ Dana Gloor
                                       --------------------------
                                       Name:  Dana Gloor
                                       Title: General Counsel